Mycoplasma hominis and Ureaplasma urealyticum infections in male urethritis and its complications.
OBJECTIVE
The aim of this study was to estimate the incidence of M. hominis and U. urealyticum infections among men with urethritis and its complications.


METHODS
Material for analysis were urethral swabs and EPS. Mycoplasma IST 2 kit was applied to diagnose mycoplasmal infections. All patients were additionaly tested for C. trachomatis, C. albicans and T. vaginalis and Gram stain specimens were obtained to identify the presence of PMN.


RESULTS
U. urealyticum was detected in 57/390 (14.6%), and M. hominis in 4/390 (1%) men. Exclusive U. urealyticum infection was found in 45 (11.5%) men, and only 2 patients had exclusive M. hominis infection. U. urealyticum infection the most frequently coexisted with C. trachomatis--5 (8.8%), next with C. albicans--4 (7%) and M. hominis--2 (3.5%) infections. Mycoplasmal infections were the most frequently found in patients aged 30 to 39 (35.1%) diagnosed with epididymitis (29.2%). The most commonly reported symptom was dysuria.


CONCLUSIONS
U. urealyticum is the common pathogen among men with urethritis and its complications. The most common symptoms in U urealyticum patients were: dysuria, hypogastric pains and urethrorrhoea, however, clinical symptoms are not frequently observed.
Zdrodowska-Stefanow
B
B
Department of Dermatology and Venerology, Medical University of Białystok, Poland.
Kłosowska
W M
WM
Ostaszewska-Puchalska
I
I
Bułhak-Kozioł
V
V
Kotowicz
B
B
D000293:Adolescent; D000328:Adult; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D009175:Mycoplasma Infections / Q000150:complications* / Q000453:epidemiology / Q000382:microbiology; D019535:Mycoplasma hominis / Q000302:isolation & purification; D011044:Poland / Q000453:epidemiology; D016869:Ureaplasma Infections / Q000150:complications* / Q000453:epidemiology / Q000382:microbiology; D016990:Ureaplasma urealyticum / Q000302:isolation & purification; D014526:Urethritis / Q000150:complications* / Q000453:epidemiology